COVID-19 Information Center

Transmission electron microscopic image of an isolate from a case of coronavirus disease (COVID-19)
  • Coronavirus disease

COVID-19 Information Center

Novartis is responding to coronavirus disease (COVID-19) with safety of associates and patients globally our primary concern. We are also contributing to research efforts, supporting communities and ensuring stable supply and price of essential medicines. This information center provides a central hub for updates, guidance and other resources.

Novartis response to COVID-19

In the face of a global crisis, Novartis has quickly mobilized R&D capabilities, medicines, clinical trials expertise and philanthropic aid to address the coronavirus disease pandemic.

Read More

Latest news

AveXis joins AAVCOVID vaccine program from Massachusetts Eye and Ear and Massachusetts General Hospital

Read More

Our industry is at an inflection point. Novartis research shows technology talent increasingly drawn to pharma industry since COVID-19, to solve healthcare challenges

Read More

Sandoz responds to increased demand for antibiotics and other essential medicines for patients during COVID-19

Read More

Novartis update following WHO Solidarity trial announcement

Read More

  • Woman looking at an Ipad in a waiting room

    Patients and Caregivers

    Novartis is working to ensure supply of our medicines, enhance virtual services, protect the integrity of clinical trials and support patient organizations during the coronavirus disease (COVID-19) pandemic.

  • Doctors washing their hands

    Healthcare Professionals

    Novartis is working closely with healthcare professionals during the coronavirus disease pandemic. We are embracing new ways of working and have rapidly scaled up multichannel engagement.

  • Businessman with digital tablet

    Investors and Shareholders

    Novartis is regularly updating our Investor and Shareholder communities on the impact of coronavirus disease (COVID-19) and our response.

  • Business people working on a computer

    Job candidates

    Novartis is supporting candidates during the coronavirus disease (COVID-19) outbreak. During this time interviews will continue as planned and, where appropriate, will be switched to virtual interviews using readily available technology.

  • Man preparing a package


    Novartis is providing suppliers with recommended good practices guidance during the coronavirus disease (COVID-19) pandemic based on the most up-to-date World Health Organization (WHO) technical information.

  • Grey and white world map

    COVID-19 country resources

    Novartis provides country-specific information about coronavirus disease (COVID-19) in local languages.

Clinical trials

Going the extra mile to keep clinical trials on track during the COVID-19 pandemic

A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.

Learn More

Novartis COVID-19 Response Fund

Novartis COVID-19 Response Fund is providing urgently-needed support for healthcare workers and communities in over 50 projects around the world.

Learn More

Research and collaborations

Joining Monocle’s The Big Interview Podcast

Novartis CEO Vas Narasimhan joins Monocle’s editor in chief, Tyler Brûlé to talk about crisis management, the vaccine race and the future of work during episode 114 of The Big Interview.

Listen to podcast

Applying H1N1 learnings to COVID-19 pandemic

NYSE called Novartis CEO Vas Narasimhan to learn how Novartis is applying what they learned from fighting H1N1 to the current COVID-19 pandemic.

Watch on IGTV

Streamlining systems to respond to COVID-19

Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.

Read More